full2010.pdf - page 555

517
„µ¦Ä®oo °¤¼¨ª·‹´¥ ץŤn¤¸Ÿ¨„¦³šÄ—Ç ˜n°„µ¦¤µ¦´¦´„¬µ¡¥µµ¨š¸ÉŸ¼o žiª¥‹³Å—o¦´ ¨³¤¸ ·š›· š¸É‹³¥»˜·„µ¦Ä®oo°¤¼¨Å—o
˜¨°—Áª¨µÄœ –³Á„ȝ o°¤¼¨Ã—¥Å¤n¤¸o °Â¤oÄ—Ç Ÿ¼ožiª¥š¸ÉÁ oµ¦nª¤„µ¦ª·‹´¥‹³ °Ä®o˜°Â°™µ¤ž¦³¤µ– 5 œµš¸
Á‡¦ºÉ°Š¤º°Á„ȝ¦ª¦ª¤ o°¤¼ ¨ Á‡¦ºÉ °Š¤º°š¸ÉčoĜ„µ¦ª·‹´ ¥ž¦³„°—oª¥ 1) ´ ¤£µ¬–ro°¤¼ ¨nªœ»‡‡¨
ž¦³„°—oª¥ °µ¥» «µœµ ™µœ£µ¡¤¦¦³—´„µ¦«¹„¬µ °µ¸¡ ¦µ¥Å—o „µ¦¼»®¦¸É 2) ž{‹‹´¥Á¸É¥Š °ŠÃ¦‡®¨°—Á¨º°—
®´ªÄ‹Ã‡Ã¦ čo Framingham Risks Score Ž¹ÉŠ„¦¼—¸Â¨³‡–³ ¡´•œµ‹µ„ Heart Study Project 宦´ž¦³Á¤·œ¦³—´ ‡ªµ¤
Á¸É¥Š„µ¦Á„·—懮¨°—Á¨º°—®´ªÄ‹Ã‡Ã¦œµ¦¸ ץĮo ‡³Âœœ˜µ¤‡ªµ¤Á¸É¥Š—o µœ °µ¥» ž¦³ª´˜·„µ¦¼» ®¦¸É ¦³—´Å ¤´œ‡¨°
Á¨Á˜°¦°¨ ¦³—´Å ¤´œÁ°—¸ °¨ ¦³—´œÊÎ µ˜µ¨ÄœÁ¨º°— ‡nµ‡ªµ¤—´œŽ¸ ب·„ nŠ¦³—´‡ªµ¤Á¸É¥Š °°„Áž}œ 4 ¦³—´
ŗo „n ¦³—´‡ªµ¤Á¸É¥Š˜É優nµ‡ªµ¤Á¸É¥ŠÁŒ¨¸É ¥ ¦³—´‡ªµ¤Á¸É¥ŠÁŒ¨¸É¥ ¦³—´ ‡ªµ¤Á¸É¥Š¼ Š„ªnµ‡ªµ¤Á¸É¥ŠÁŒ¨¸É¥žµœ„¨µŠ
¨³¦³—´ ‡ªµ¤Á¸É¥Š¼Š ¨oªÁš¸¥¦³—´‡³ÂœœÁ¡ºÉ°ª·Á‡¦µ³®r¦³—´‡ªµ¤Á¸É ¥Š˜n°„µ¦Á„·—懮¨°—Á¨º°—®´ªÄ‹Ã‡Ã¦œµ¦¸
„µ¦ª·Á‡¦µ³®ro°¤¼¨ ª·Á‡¦µ³®ro°¤¼ ¨Ã—¥Äoަ„¦¤ÎµÁ¦È‹¦¼ž „µ¦˜¦ª‹° o°¤¼ ¨ÁºÊ°Š˜oœ‹µ„„¨»n¤˜´ª°¥nµŠ
‹Îµœªœ 324 ¦µ¥ Ťn¡ªnµ˜´ªÂž¦š¸É«¹ „¬µ¤¸o°¤¼¨ µ—®µ¥ ¨³Å¤n ¡˜´ªÂž¦Ä—¤¸‡nµ¼Š®¦º°‡n µ˜É執—ž„˜· o°¤¼ ¨nªœ
»‡‡¨Â¨³ o°¤¼ ¨»£µ¡Â¨³‡ªµ¤Á‹Èžiª¥ ª· Á‡¦µ³®rץčo„µ¦Â‹„‹Š‡ªµ¤™¸É ¦o °¥¨³ ‡nµÁŒ¨¸É ¥ ¨³nªœÁ¸É ¥ŠÁœ
¤µ˜¦“µœ ¦³—´‡ªµ¤Á¸É ¥Š˜n°„µ¦Á„· —懮¨°—Á¨º°—®´ªÄ‹Ã‡Ã¦œµ¦¸ ‹µ„„µ¦ž¦³Á¤·œž{ ‹‹´¥Á¸É ¥Š˜µ¤ÂœªšµŠ¤µ˜¦“µœ
°Š Framingham Risks Scores ª·Á‡¦µ³®r ץčo„µ¦Â‹„‹Š‡ªµ¤™¸É ¦o°¥¨³ ‡nµÁŒ¨¸É¥ ¨³nªœÁ¸É¥ŠÁœ¤µ˜¦“µœ
ª·Á‡¦µ³®r‡ªµ¤´¤¡´œ›r¦³®ªnµŠž{‹‹´¥Á¸É¥ŠÂ¨³¦³—´‡ªµ¤Á¸É¥Š˜n °„µ¦Á„·—懗oª¥ odds ratio
Ÿ¨„µ¦ª·‹´¥Â¨³°£· ž¦µ¥Ÿ¨
„¨»n¤˜´ª°¥n µŠš´ÊŠ®¤— 324 ‡œÁž}œÁ¡«®·ŠÂ¨³œ´™º°«µœµ¡» š› °µ¥» 33-95 že ÁŒ¨¸É¥ 66.89 + 11.55 že
ž¦³¤µ– 1 Ĝ 3 ¤¸°µ¥»¦³®ªnµŠ 61-70 že (33.3%) Ž¹ÉŠÄ„¨o Á‡¸¥Š„´ nªŠ°µ¥» 71-80 že (29.3%) ž¦³¤µ– 3 Ĝ 4 ¤¸ ™µœ£µ¡
¤¦‡¼n (71.3%) nªœÄ®n‹„µ¦«¹„¬µ¦³—´ž¦³™¤«¹„¬µ (75%) „¨»n¤˜´ ª°¥nµŠ¤µ„„ªnµ‡¦¹É Šž¦³„°°µ¸¡Á„¬˜¦„¦¦¤
(53.1%) nªœÄ®n¤¸¦µ¥Å—o < 5,000 µš (87.7%) n ªœÄ®n¤¸‡ªµ¤—´œÃ¨®·˜°¥¼nĜ¦³—´ Pre-hypertension (34.23 –
40.7%) ¦°Š¨Š¤µ‡º°¦³—´‡ªµ¤—´ œÃ¨®·˜ž„˜· (32.7 - 35.80%) „¨»n¤˜´ª°¥nµŠnªœÄ®n¤¸‡ªµ¤—´œÃ¨®·˜¼ŠÁŒ¡µ³‡ªµ¤—´œ
Ž¸ ب·„ (88.10%) ‡nµÁŒ¨¸É¥ °Š‡ªµ¤—´œŽ¸ ب·„Ášnµ„´ 133.28 + 10.59 (112-164 mmHg) „¨»n ¤˜´ª°¥nµŠ¤µ„„ªnµ‡¦¹ÉŠ¤¸
¦³—´œÊÎ µ˜µ¨ÄœÁ¨º°— < 100 mg% (55.2%) ž¦³¤µ– 1 Ĝ 3 ¤¸¦³—´œÊÎ µ˜µ¨ÄœÁ¨º°— 100-125 mg% (30.9%) nªœ„¨»n¤š¸É¤¸
¦³—´ œÊ嘵¨ÄœÁ¨º°— > 126 mg% ¤¸Â‡n¦o°¥¨³ 13.9 ‡n µÁŒ¨¸É¥ °Š¦³—´œÊ嘵¨ÄœÁ¨º °— °Š„¨»n¤˜´ª°¥nµŠÁšnµ„´  105.42 +
28.32 mg% (68-278 mg%) „¨»n¤˜´ª°¥nµŠ¤µ„„ªnµ‡¦¹É Š¤¸¦³—´‡¨°Á¨Á˜°¦°¨ < 200 mg/dL (59.6%) nªœ¦³—´ ‡¨°
Á¨Á˜°¦°¨ 200-239 mg/dL ¨³ > 240 mg/dL ¤¸‹ÎµœªœÄ„¨o Á‡¸¥Š„´ œ (21.9% ¨³ 18.5%) ‡nµÁŒ¨¸É ¥ °Š¦³—´‡¨°